Project Scope
To evaluate the value and potential evidence of a vaccine for HPV prevention, and understand prescribing expectations and price perceptions in South Africa
SA
Challenge
Our client is a leading provider of vaccines for infectious diseases. They wanted to understand the factors influencing the patient purchasing decisions, assess HCPs perception towards HPV, alongside evaluate the value and pricing potential of a new vaccine
Solution
Conducted extensive primary research to get detailed insights on:
- Landscape assessment and drivers of healthcare spending in the HPV space
- Assessment of the new HPV vaccine and prescribing expectations
- Price perceptions and willingness to pay at specific price points in the private market
Results
- Successfully enabled our client to understand considerations that influence the adoption of a HPV vaccine in the private market
- Refined the clients pricing strategy by unveiling the likely price points at which patients would be willing to purchase out-of-pocket
Note: HPV: Human Papillomavirus, P&MA: Pricing and market access
